Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0106732 Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions...
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine,...
2016/0106731 TRICYCLIC INDOLE MCL-1 INHIBITORS AND USES THEREOF
The present invention provides for compounds that inhibit the activity of an anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The...
2016/0106730 Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions...
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine,...
2016/0106729 Group of Alkaloids, the Novel Autophagic Enhancers for Treatment of Cancers and Neurodegenerative Conditions...
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine,...
2016/0106728 METHODS AND COMPOSITIONS FOR TREATING BETA-THALASSEMIA AND SICKLE CELL DISEASE
Compounds, pharmaceutical compositions, and methods for treating anemia .beta.-thalassemia anemia or sickle cell anemia.
2016/0106727 COMPOSITION AND METHOD FOR THE TREATMENT OF NEURODEGENERATION
A composition and method for the treatment of neurodegeneration and brain-derived neurotrophic factor. The composition and method comprising providing...
2016/0106726 PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCY
Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2...
2016/0106725 Novel bis-Benzylidine Piperidone Proteasome Inhibitor with Anticancer Activity
We describe a bis-benzylidine piperidone, RA190, which covalently binds to the ubiquitin receptor RPN13 (ADRM1) in the 19S regulatory particle and inhibits...
2016/0106724 HUMAN THERAPEUTIC AGENTS
Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all...
2016/0106723 METHODS TO SENSE AND TREAT SUBCLINICAL SKIN DAMAGE
A method of sensing and removing subclinical, precancerous cells from skin wherein the unblemished skin is not being treated for AK, fine lines or clinical...
2016/0106722 HUMAN THERAPEUTIC AGENTS
Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all...
2016/0106721 HUMAN THERAPEUTIC AGENTS
Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all...
2016/0106720 MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
The instant invention describes macrocyclic compounds having therapeutic activity, and methods of treating disorders such as methods of modulating bone...
2016/0106719 Transplantation Adjuvant in Cell Therapy Using Neural Progenitor Cells
The present invention provides a transplantation adjuvant for neural progenitor cells containing valproic acid and/or zonisamide as an active ingredient.
2016/0106718 CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS
This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of...
2016/0106717 CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS
This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of...
2016/0106716 Solid Dosage Forms of Bendamustine
In the present invention there is provided a pharmaceutical composition in a solid dosage form suitable or oral administration, the composition comprising...
2016/0106715 METHODS TO INHIBIT INFECTION DURING WOUND HEALING WITH TOPICAL COMPOSITIONS INCLUDING AMINO ACIDS
A method that inhibits infection during wound healing by topical application of a single composition, which contacts a wound for a period of time to initiate...
2016/0106714 AQUEOUS-BASED METRONIDAZOLE GEL FORMULATIONS
The present disclosure provides mucoadhesive aqueous-based gel formulations of metronidazole useful for a variety of purposes, including intravaginal...
2016/0106713 NITRIC OXIDE SCAVENGERS
Therapeutic compositions capable of removing excess nitric oxide are provided. The therapeutic compositions include nitronyl nitroxide monoradicals, B12...
2016/0106712 FATTY ACID COX INHIBITOR DERIVATIVES AND THEIR USES
The invention relates to fatty acid COX inhibitor derivatives; compositions comprising an effective amount of a fatty acid COX inhibitor derivative; and...
2016/0106711 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2)...
2016/0106710 WOUND HEALING VIA AUTOLOGOUS STEM CELL MOBILIZATION
The present invention relates to the field of wound healing. More specifically, the present invention provides methods and compositions useful for improved...
2016/0106709 VITAMIN C AND CHROMIUM-FREE VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING AN NFKB-MEDIATED CONDITION OR DISEASE
Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable...
2016/0106708 USE OF ANTIOXIDANTS FOR THE TREATMENT OF COGNITIVE AND BEHAVIOURAL DISORDERS IN INDIVIDUALS WITH FRAGILE X SYNDROME
The invention relates to the use of antioxidants such as, ascorbic acid (Vitamin C), Tocopherol (Vitamin E), vitamin A and polyphenols, for the treatment of...
2016/0106707 METHOD FOR OBTAINING A STABLE GEL OF HYALURONIC ACID AND OF A FREE FORM OF VITAMIN C AND/OR A SALT THEREOF
The invention relates to a process for producing an aqueous gel comprising hyaluronic acid, vitamin C, and a stabilizing agent selected from the...
2016/0106706 METHOD OF DELIVERING AN ANTI-CANCER AGENT TO A CELL
There is provided a delivery vehicle comprising an anti-cancer agent together with a conjugate of a delivery agent containing a free aldehyde and a flavonoid,...
2016/0106705 CANNABIS EXTRACTS AND METHODS OF PREPARING AND USING SAME
The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical...
2016/0106704 METHODS FOR DELIVERING CROMOLYN
Methods of delivering cromolyn to a patient in need thereof, methods of treating amyloid-associated conditions and inflammatory or allergic lung diseases, and...
2016/0106703 FUMAGILLOL TYPE COMPOUNDS AND METHODS OF MAKING AND USING SAME
The disclosure provides a fumagillol type compound and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of...
2016/0106702 METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs
The present invention is directed to methods of treating, preventing, suppressing and/or inhibiting urological disorders such as urinary incontinence including...
2016/0106701 METHOD FOR PREVENTING AND/OR TREATING HAIRY WART DISEASE
Provided is a novel method for preventing and/or treating hairy wart disease which is a hoof and leg disease of ungulates. The method is carried out by...
2016/0106700 Pharmaceutical Formulation for Histone Deacetylase Inhibitors
A pharmaceutical composition, comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) compound represented by the following...
2016/0106699 Oral pharmaceutical composition containing combination of PPARa and a HMG-CoA reductase inhibitor
Oral pharmaceutical composition containing, in the same pharmaceutical form, effective amounts of a HMG-CoA reductase inhibitor derivative and of PPAR.alpha.,...
2016/0106698 Compositions And Methods Of Use Of Phorbol Esters
Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such...
2016/0106697 METHODS FOR MAKING RETINOIDS AND USES THEREOF
Described herein are methods for making retinoids. Also described herein are retinoids and methods of use thereof.
2016/0106696 PHARMACEUTICAL PRODUCT, MEDICAL FOOD OR DIETARY SUPPLEMENT FOR PREVENTING CANCER AND INFLAMMATORY DISEASES
The present invention relates to cancer therapy by administering a specific dietary composition. Especially the invention relates to a pharmaceutical, medical...
2016/0106695 PETROSELINIC ACID OR A COMBINATION OF ACTIVE INGREDIENTS COMPRISING AT LEAST PETROSELINIC ACID FOR PROMOTING...
The present invention relates to the field of weight management and obesity. It concerns petroselinic acid or a combination of active ingredients including at...
2016/0106694 PHARMACEUTICAL COMPOSITIONS COMPRISING DROXIDOPA
The present invention provides combinations of droxidopa and one or more further pharmaceutically active compounds, said further compounds preferentially being...
2016/0106693 MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR TREATING NEURODEGENERATIVE DISEASES WITH PARKINSONIAN...
A composition for treating Neurodegenerative Diseases with Parkinsonian Syndromes in a subject in need thereof, wherein the composition includes an effective...
2016/0106692 USE OF X-RAY CONTRAST MEDIA AND RELATED COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF A FILOVIRUS INFECTION
Embodiments disclosed herein relate to certain compositions including X-ray contrast media compounds and/or certain tri-iodinated phenyl compounds and methods...
2016/0106691 CHEMICAL CHAPERONINS AS NOVEL MOLECULAR MODULATORS OF BETA PROTEIN AGGREGATION PRESENT IN CONFORMATIONAL DISEASES
This invention relates to chemistry and biochemistry applied to the field of medicine and is referred to a new method of prevention and therapeutic treatment...
2016/0106690 PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES
The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of...
2016/0106689 USE
The present invention relates to compositions comprising cysteamine or a derivative thereof for use in treating infections caused by yeasts or moulds.
2016/0106688 Parenteral Administration of Tapentadol
An aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a pH value of at...
2016/0106687 HUMAN THERAPEUTIC AGENTS
Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all...
2016/0106686 MULTILAMINATE BACKING CONSTRUCTION
A novel backing construction for a transdermal drug delivery system is disclosed. In particular, the invention relates to a system and method for labeling a...
2016/0106685 CIPROFLOXACIN LOADED DIETHYLAMINOETHYL CELLULOSE NANOPARTICLES
This invention reports ciprofloxacin (CIP)-encapsulated polymeric nanoparticles and its antibacterial potential with a variety of gram positive and gram...
2016/0106684 CASEIN COATED DRUG-LOADED IRON OXIDE NANOPARTICLES
This disclosure relates to nanoparticle drug delivery systems composed of casein (CN) coated nanoparticles, e.g., iron oxide nanoparticles coated with an inner...
2016/0106683 TIMED, PULSATILE RELEASE SYSTEMS
A unit multiparticulate dosage form for delivering one or more basic, active pharmaceutical ingredients into the body in need of such medications to achieve...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.